Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2026-06-03 17:02:06 ET · period of report 2026-06-01 · accession 0001104659-26-070155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-03 17:02 | 2026-06-01 | IOVA | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | +41.7K | 571.2K | +8% | $0 |
| D | 2026-06-03 17:02 | 2026-06-01 | IOVA | Vogt Frederick G | GC, Interim CEO, Dir | F - Tax | $3.96 | -17.7K | 553.5K | -3% | -$70.1K |
| D | 2026-06-03 17:02 | 2026-06-01 | IOVA | Vogt Frederick G | GC, Interim CEO, Dir | M - OptEx | $0.00 | -41.7K | 125.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 41,668 | $0.00 | 571,206 | D | — | — | (F1) Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
| 2 | Common | Common Stock | 2026-06-01 | F | D | 17,701 | $3.96 | 553,505 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. (F3) Represents common stock remaining after deducting the common stock withheld for taxes. |
| 3 | Derivative | Restricted Stock Units | 2026-06-01 | M | D | 41,668 | $0.00 | 125,007 | D | — · — to — | 41,668 Common stock | (F4) Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F5) The remaining RSUs will vest in equal quarterly installments. (F5) The remaining RSUs will vest in equal quarterly installments. (F6) Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |